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Introduction: High blood pressure (BP) is a well-known major risk factor for cardiovascular diseases and is a
leading contributor to cardiovascular mortality and morbidity worldwide. Reliable population-based BP data
from lowmiddle income countries are sparse.
Objective: This paper reports BP distributions among adults in nine rural populations in five Asian countries
and examines the association between high BP and associated risk factors, including gender, age, education,
and body mass index.
Methods: A multi-site cross-sectional study of the major non-communicable disease risk factors (tobacco and
alcohol use, fruit and vegetable intake, physical activity patterns) was conducted in 2005 in nine Health and
Demographic Surveillance System (HDSS) sites in five Asian countries, all part of the INDEPTH Network.
In addition to the self-report questions on risk factors, height and weight, and BP were measured during
household visits using standard protocols of the WHO STEPwise approach to Surveillance.
Results: In all the study sites (except among men and women in WATCH and among women in Chililab), the
mean levels of systolic BP were greater than the optimal threshold (115 mmHg). A considerable proportion of
the study populations  especially those in the HDSS in India, Indonesia, and Thailand  had high BP
(systolic BP]140 mmHg or diastolic BP]90 mmHg or on treatment with BP medications). A more
conservative definition of high BP (systolic BP]160 mmHg or diastolic BP]100 mmHg) substantially
reduced the prevalence rate. The marked differences in the proportion of the populations on high BP
medication (range between 0.6 and 10.8%) raised problems in comparing the prevalence of high BP across
sites when using the commonly used definition of high BP as in this study. In the four HDSS in Bangladesh,
women had a higher prevalence of high BP than men; the reverse was true in the other sites (Chililab, Filabavi
in Vietnam; Kanchanaburi, Thailand; and Vadu, India) where men experienced higher prevalence than
women. Overweight and obesity were significantly associated with high BP, with odds ratio ranging from two
in Chililab to five in Filabavi (both in Vietnam HDSS).
Conclusion: The patterns of BP in these nine cross-sectional surveys were complex, reflecting the fact that the
Asian countries are at different stages of the epidemiological transition. Actions to prevent the rise of BP
levels are urgently required. An emphasis should be placed on cost-effective interventions to reduce salt
consumption in the population as an immediate priority.
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H
igh blood pressure is a major modifiable risk
factor for cardiovascular diseases (CVDs) and a
leading cause of the CVD burden worldwide (1).
The higher the blood pressure, the greater the chance of
heart attack, heart failure, stroke, and kidney disease (2).
High blood pressure is only one of several proven
modifiable risk factors for CVDs and decisions about
treatment need to be based on overall risk and the
presence of other risk factors rather than the level of
blood pressure alone. The other major risk factors
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healthy diet, and physical inactivity (3). Clustering of risk
factors cause a majority of CVD events (46).
A recent systematic review reported that the prevalence
of high blood pressure in low and middle-income
countries is reaching the level in high income countries
(7); approximately half of all CVD in low and middle-
income countries is related to high blood pressure (8).
Asian countries are undergoing an epidemiological
transition with an increasing burden of CVDs and their
risk factors (911). Information on the pattern and trends
in blood pressure in these countries is important for
health professionals to direct health planning, health
resourcing, and public health interventions. Taking
advantage of a cross-site study on non-communicable
disease risk factors conducted in 2005, this paper reports
the pattern of blood pressure among adult men and
women in the study settings in nine Health and Demo-
graphic Surveillance System (HDSS) sites from five Asian
countries (12) and examines the association with gender,
age, education, and body mass index. The paper also
addresses the issue of treatment guidelines in the context
of these resource-constrained settings.
Methods
The study was based on the WHO STEPwise approach to
Surveillance (WHO STEPS). Details have been described
elsewhere (1214). Briefly, a cross-sectional study of the
major non-communicable disease risk factors (tobacco
and alcohol use, fruit and vegetable intake, physical
activity patterns) was conducted in 2005 in nine HDSS
sites in five Asian countries, all part of the INDEPTH
Network (an International Network of field sites for
continuous Demographic Evaluation of Populations and
Their Health in developing countries), which was estab-
lished to facilitate linkage of existing demographic field
sites (15).
In addition to the self-report questions on tobacco and
alcohol use, fruit and vegetable intake and physical
activity patterns, height and weight, and blood pressure
were measured during household visits using standard
protocols. Training was undertaken prior to the study
start and all sites used the same automated blood
pressure measuring devices (Omron M3†). Blood pres-
sure was measured at the right arm at heart level after a
period of 10 minutes of rest. Three measurements were
taken and the averages of the last two readings were used
in the analysis. Strict training protocols for data collec-
tors were adhered to and quality assurance measures were
employed to ensure the quality of the data collected.
Both descriptive and analytical statistics were carried
out using Stata 10 software (Stata Corporation). Mean
blood pressure levels (and 95%CI) were computed.
Proportions of high blood pressure using different cut-
offpoints(andtheir95%CIs)stratifiedbyageandsexwere
also calculated. Careful attention was paid to the levels of
high blood pressure treatment to understand the compar-
abilityof data obtained in these different settingswhen the
standard definition of hypertension was used in defining
the proportion of high blood pressure. Multivariable
regression modeling was performed to examine the
associations between high blood pressure with age, sex,
education, and body mass index. A significance level of
pB0.05 was used.
Ethical considerations
The protocol of this study was approved by the Scientific
Board of the INDEPTH Network and was also in
accordance with the ethics codes of the respective sites.
All human subjects in the study were asked for their
verbal and written informed consent before data were
collected, and all had the right to withdraw from the
study at any time.
Results
The mean levels of systolic blood pressure (SBP) and
diastolic blood pressure (DBP) of the study subjects by
site and sex are shown in Figs. 1 and 2. Among men,
mean SBP was lowest in one of the sites in Bangladesh
and highest in Purworejo, Indonesia; DBP was lowest in
Matlab and highest in Vadu. Among women, SBP was
lowest in Chililab, Vietnam and highest in Kanchanaburi,
Thailand; DBP was lowest in Filabavi, Vietnam and
highest in Mirsarai, Bangladesh.
The proportion of study subjects who had high blood
pressure according to two different cut points are
presented for men and women in Table 1. When SBP
]140 mmHg or DBP]90 mmHg was used as a cut
point, the overall prevalence (men and women combined)
ranged from around 15 to 28% of the adult population
with one exception where prevalence was 9% in one of the
HDSS in Bangladesh. When a higher cut point was used
(SBP]160 mmHg or DBP]100 mmHg), prevalence
halved (ranging from 5 to 15%). A greater proportion of
women had high blood pressure than men in the four
HDSS in Bangladesh; in the other HDSS, men had a
higher prevalence than women.
Table 2 shows differences in treatment patterns for
raised blood pressure according to blood pressure levels
as well as overall treatment. One in 10 of the population
in one of the HDSS in Bangladesh (Mirsarai) reported
being on anti-hypertensive treatment. In contrast, treat-
ment for raised blood pressure was reported in only 2% of
the respondents in Vadu, India and Purworejo, Indone-
sia. Women reported higher levels of blood pressure
treatment than men in almost in all HDSS sites except in
the Vietnamese sites where more men reported receiving
anti-hypertensive treatment compared with women. Of
particular note is the variation in the proportion of the
population on anti-hypertensive treatment whose blood
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61pressure was controlled (B140/90). This ranged from less
than 1 to 11%.
Multivariable logistic regression models were con-
structed to analyse the association of high blood pressure
with age, gender, education, and body mass index (Table
3). The models show that age is a significant determinant
of high blood pressure in both men and women. The
models also show that while high blood pressure was
shown to be significantly more common in men than in
women in the two HDSS in Vietnam and Kanchanaburi
in Thailand, it was significantly more prevalent in
women in the four Bangladeshi sites (Matlab, Mirsarai,
Abhoynagar, and WATCH). Overweight (defined as
BMI]25 kg/m
2) was shown to be positively associated
with high blood pressure in all sites. There was a
tendency for increasing levels of education to be
associated with increased blood pressure in Matlab and
WATCH of Bangladesh.
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Fig. 1. Mean systolic blood pressure (mmHg) (95%CI) in nine HDSS sites, by gender.
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Fig. 2. Distribution of diastolic blood pressure (mmHg) and its 95%CI in nine HDSS sites by gender.
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62Discussions
This study provides information on the patterns of blood
pressure among adult populations in countries in Asia
which are undergoing the epidemiologic transition. The
data are reliable and accurate as the study was conducted
within well-functioning HDSSs using standardised WHO
STEPS protocols (13). The data provide baseline mean
population levels of blood pressure for men and women
against which future measures of blood pressure within
the HDSS framework can be compared. High blood
pressure is only one of many modifiable risk factors
which contribute to an increased risk of CVD (16).
In all the study sites (except among men and women in
WATCH and among women in Chililab), the mean levels
of SBP were greater than the optimal threshold (i.e. 115
mmHg; Fig. 1). Suboptimal SBP level (i.e. greater than
115 mmHg) has been estimated to account for 62% of all
cerebrovascular disease and 49% of all ischemic heart
disease (5). This study showed that a considerable
proportion of the study populations had raised blood
pressure, especially in the sites in Vietnam, Indonesia,
Thailand, and India. The overall prevalence of hyperten-
sion (blood pressure]140/90 mmHg) found in this study
were higher than reported in other studies in Vietnam,
Indonesia (17), Thailand (18), India (19), and Bangladesh
(20). However these comparisons are hindered because of
differences in age structure, variability in definition of
hypertension, time of the study, urban versus rural
characteristics of the population, and standardisation
of blood pressure measurement instruments and proce-
dures.
Another important consideration in comparisons be-
tween studies, and time-series studies, relates to the
standard and widely used definition of hypertension
(SBP]140 mmHg or DBP]90 mmHg or on anti-
hypertensive treatment). Between 0.6 and 10% of people
in these nine HDSS were classified as ‘hypertensive’ based
on treatment alone (i.e. blood pressure levels were below
140/90 mmHg). Had these been included, the prevalence
would have been up to 10% higher in some of the HDSS.
The inclusion of the ‘controlled’ category in the defini-
tion of hypertension thus artificially increases prevalence,
making comparisons of the burden of high blood
pressure between sites/countries or across different time-
points invalid, when the treatment patterns are consider-
ably different across different settings. The more people
who receive anti-hypertensive treatment and the more the
treatment is successful in lowering blood pressure below
140/90 mmHg, the higher the prevalence, according to the
standard definition. It is for this reason that changes in
mean population levels of blood pressure offer a more
accurate measure of change over time.
Our data also confirms that the burden of raised blood
pressure depends on the cut-off points used. In fact, there
is no clear threshold value which separates hypertensive T a b l e
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63Table 2. Percent (95%CI)) of men and women on treatment by different blood pressure groups in nine HDSS sites
Bangladesh India Vietnam Indonesia Thailand
Matlab Mirsarai Abhoynagar WATCH Vadu Chililab Filabavi Purworejo Kanchanaburi
Men
SBPB140 and DBPB90 8.2 (6.210.2) 10.8 (8.613.1) 7.5 (5.79.4) 3.7 (2.45.1) 1.7 (0.82.7) 2.6 (1.63.6) 2.5 (1.53.5) 1.4 (0.52.3) 4.9 (3.46.4)
SBP]140 or DBP 90 14.9 (9.220.5) 21.2 (15.427.1) 22.7 (15.929.5) 15.2 (7.822.5) 7.1 (3.710.5) 13.3 (7.818.8) 13.1 (6.519.7) 5.9 (2.79) 20.4 (15.325.6)
SBP]160 or DBP]100 26 (14.737.3) 23 (12.933.2) 28.8 (15.941.7) 16 (1.130.8) 2.9 (1.16.9) 41.8 (24.359.2) 8.6 (3.220.4) 9.3 (3.115.5) 31.5 (20.742.3)
All men 3.1 (24.2) 7.8 (6.19.5) 6.1 (4.67.6) 1.7 (0.92.5) 1.4 (0.72.1) 5.5 (4.26.8) 5.1 (3.76.5) 2.2 (1.33) 5.6 (4.27)
Women
SBPB140 and DBPB90 2.1 (1.13.1) 5.9 (4.27.5) 3.9 (2.65.2) 1 (0.31.6) 0.7 (0.11.3) 3 (1.94.1) 3.9 (2.65.3) 0.6 (01.1) 2.8 (1.64)
SBP]140 or DBP]90 11.7 (5.318) 18.5 (12.624.4) 25.8 (17.434.2) 12.3 (4.320.3) 3.5 (1.25.8) 15.6 (1120.3) 10.5 (615) 6.7 (3.69.9) 11.5 (815.1)
SBP]160 or DBP]100 13.8 (1.429.1) 22.1 (12.231.9) 45.8 (28.663) 11.6 (9.432.7) 1.7 (1.64.9) 25.4 (13.237.6) 13 (4.821.3) 18 (8.927) 9.7 (3.715.8)
All women 9.1 (7.211) 12.8 (10.614.9) 9.5 (7.711.4) 4.6 (3.26) 2.8 (1.83.8) 3.9 (2.85.1) 3.3 (2.24.4) 2.5 (1.53.5) 8 (6.49.6)
Total
SBPB140 and DBPB90 5.4 (4.26.6) 8.5 (79.9) 5.8 (4.77) 2.4 (1.63.1) 1.2 (0.71.8) 2.8 (23.5) 3.1 (2.34) 1 (0.51.5) 4 (35)
SBP]140 or DBP]90 13.6 (9.417.9) 20.1 (15.924.3) 23.9 (18.629.2) 13.9 (8.519.3) 5.1 (3.17.1) 14.7 (11.118.3) 11.4 (7.715.1) 6.3 (4.18.5) 15.5 (12.418.5)
SBP]160 or DBP]100 22.6 (13.331.8) 22.6 (15.429.8) 34.8 (24.445.2) 14.6 (2.526.7) 2.3 (0.34.8) 31.9 (21.642.2) 11.6 (4.918.3) 12.8 (7.618) 20.2 (13.826.5)
All 6.4 (5.37.6) 10.4 (9.111.8) 7.9 (6.79.2) 3.2 (2.44) 2.1 (1.52.7) 4.7 (3.85.6) 4.2 (3.35.1) 2.3 (1.73) 6.8 (5.87.9)
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4Table 3. Association (OR and 95%CI) between demographic variables and raised blood pressure (]140/90 and/or on treatment) in nine HDSS sites
Bangladesh India Vietnam Indonesia Thailand
Variables Matlab Mirsarai Abhoynagar WATCH Vadu Chililab Filabavi Purworejo Kanchanaburi
Sex
Men 0.45 (0.350.59) 0.64 (0.510.8) 0.59 (0.460.76) 0.54 (0.40.74) 1.13 (0.91.43) 1.79 (1.422.26) 2.44 (1.863.2) 1.15 (0.911.45) 1.86 (1.52.3)
Women 1 1 1 1 1 1 1 1 1
Age groups (years)
253 41111111 1 1
3544 1.74 (1.172.59) 1.47 (1.062.04) 1.58 (1.052.39) 2.1 (1.243.56) 1.98 (1.412.77) 1.7 (1.182.45) 2.22 (1.433.43) 2.21 (1.463.35) 1.71 (1.252.35)
4554 2.75 (1.874.04) 2.01 (1.452.77) 2.52 (1.73.73) 3.46 (2.095.74) 2.53 (1.83.56) 2.54 (1.83.6) 3.19 (2.084.9) 4.87 (3.247.31) 2.55 (1.863.51)
5564 4.8 (3.287.01) 3.67 (2.685.03) 5.09 (3.497.42)5.01 (3.038.3) 3.72 (2.595.33) 3.5 (2.474.95) 6.61 (4.3410.08) 10.27 (6.8215.47) 3.79 (2.785.17)
Highest education
No schooling and
not graduated from
primary school
1111111 1 1
Graduated from
primary school
1.06 (0.771.47) 0.95 (0.651.38) 1.04 (0.671.61) 2.03 (1.273.23) 0.88 (0.611.27) 1.03 (0.651.64) 0.55 (0.330.92) 0.91 (0.691.2) 0.91 (0.721.15)
Graduated from
secondary school
1.57 (0.952.59) 1 (0.751.32) 1.28 (0.931.76) 1.65 (0.972.81) 0.99 (0.711.37) 0.97 (0.651.46) 0.63 (0.420.93) 0.9 (0.621.3) 0.96 (0.641.46)
Graduated from high
school or university
1.97 (1.283.04) 1.17 (0.741.84) 0.98 (0.531.82) 2.06 (1.133.75) 1.17 (0.841.62) 0.8 (0.531.22) 0.82 (0.511.31) 1.21 (0.831.78) 0.95 (0.661.38)
Overweight
N o 1111111 1 1
Yes 3.21 (2.284.53) 2.11 (1.532.92) 2.67 (1.893.77) 3.44 (2.125.58) 3.29 (2.494.36) 2.03 (1.392.96) 4.94 (2.579.5) 2.51 (1.863.37) 2.42 (1.953)
Note: Figures are OR (95%CI).
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5patients who will experience future cardiovascular events
from those who will not. Risk of CVD depends on blood
pressure, coexistent risk factors, and whether there is
hypertensive damage to target organs (21). It would also
be inappropriate to assume that up to one-fifth of the
adult population in these poor rural sites should be
offered treatment. Treatment decisions need to be based
on identification individuals at a high risk of disease, not
on blood pressure levels alone. Another paper in this
supplement shows that a substantial proportion in most
study populations already have three or more risk factors
for CVD (22).
Treatment decisions regarding hypertensive patients
based on cardiovascular risk are more cost-effective than
those based on blood pressure levels alone, and also
improve health outcomes (23). Numerous methods for
assessing absolute cardiovascular risk have been de-
scribed (21, 23). Secondary prevention through anti-
hypertensive treatments solely may be hard to justify in
the absence of primary intervention to promote lower
salt-intake in the population aimed at shifting the
population distribution of blood pressure to a lower level.
High-risk intervention against CVDs is available for
low-resource settings (27). Scaling up a multidrug regi-
men (a statin, aspirin, and two blood-pressure-lowering
medicines) could avert 17.9 million deaths worldwide
from CVD. This intervention would be directed at people
on the basis of overall risk and would include those who
have already suffered a heart attack, stroke, or Transient
Ischemic Attack (TIA) as well as those whose overall risk
is 15% or greater over 10 years. It assumes opportunistic
screening, not population screening, and treatment
through existing primary health care systems. This
intervention, if widely applied, would cost from $0.43
to $0.90 per person per year in low and middle-income
countries and meet three-quarters of the proposed global
chronic disease goal with only a moderate increase in
health expenditure (23). Ideally, a combination of popu-
lation-wide and high-risk preventive strategies need to be
implemented (24).
This study also revealed that the rates of control of
high blood pressure in the study populations appeared to
be low. Similar findings have also been reported for in
other studies in the region (23, 25). Factors that may
contribute to these poor rates of control include inade-
quate or inappropriate treatment, unavailability of drugs,
insufficient advice from health-care providers, and lackof
follow-up (25). In many of the countries included in this
study, out-of-pocket payments are made for drugs and
many are unable to sustain long-term costs. Appropriate
guidelines, adapted to local settings are required. The
WHO CVD-risk management package for low and
medium-resource settings is particularly appropriate for
this purpose (18). It has been designed for assessment and
management of individuals with elevated blood pressure
but can also be applied for smoking (16).
The strong associations between high blood pressure
and gender, age, education, and body mass index have
been confirmed in these rural HDSS. Our study also
confirmed that overweight and obesity increase the risks
of high blood pressure. These findings are in line with
many other studies (2527).
In summary, our findings showed that blood pressure
in Asian INDEPTH sites is a problem, both because of
its high prevalence, high mean levels, and the low rates of
control in the population. The patterns of blood pressure
from these nine HDSSs are complex to interpret but may
reflect that the Asian countries are at different stages of
the epidemiological transition. Greater attention to
actions to prevent CVD and other chronic diseases in
these setting are required. The highest priorities should
be the implementation of cost-effective population-wide
approaches to lowering the average level of blood
pressure in the population. Population-wide interventions
to promote less salt-intake in the population will shift the
population distribution of blood pressure to lower levels.
Individual high-risk approach is also feasible when
treatment decisions are based on the risk of disease,
rather than on the level of a single risk factor blood
pressure. It is to be hoped that the information from this
study will help in making planning and policy decisions
more rational.
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